nodes	percent_of_prediction	percent_of_DWPC	metapath
Thiabendazole—CYP1A2—Imiquimod—skin cancer	0.271	0.317	CbGbCtD
Thiabendazole—CYP1A1—Dacarbazine—skin cancer	0.255	0.298	CbGbCtD
Thiabendazole—CYP1A2—Vemurafenib—skin cancer	0.148	0.174	CbGbCtD
Thiabendazole—CYP1A2—Dacarbazine—skin cancer	0.114	0.133	CbGbCtD
Thiabendazole—CYP1A2—Fluorouracil—skin cancer	0.0667	0.0781	CbGbCtD
Thiabendazole—Visual acuity reduced—Temozolomide—skin cancer	0.00296	0.0203	CcSEcCtD
Thiabendazole—Lymphadenopathy—Imiquimod—skin cancer	0.0025	0.0171	CcSEcCtD
Thiabendazole—Cholestasis—Temozolomide—skin cancer	0.00232	0.0159	CcSEcCtD
Thiabendazole—Liver injury—Temozolomide—skin cancer	0.00209	0.0143	CcSEcCtD
Thiabendazole—Numbness—Fluorouracil—skin cancer	0.00196	0.0134	CcSEcCtD
Thiabendazole—Stevens-Johnson syndrome—Vemurafenib—skin cancer	0.00191	0.0131	CcSEcCtD
Thiabendazole—Sensory loss—Fluorouracil—skin cancer	0.00187	0.0128	CcSEcCtD
Thiabendazole—Coordination abnormal—Temozolomide—skin cancer	0.00179	0.0123	CcSEcCtD
Thiabendazole—Dyspepsia—Vismodegib—skin cancer	0.00175	0.012	CcSEcCtD
Thiabendazole—Decreased appetite—Vismodegib—skin cancer	0.00173	0.0118	CcSEcCtD
Thiabendazole—Fatigue—Vismodegib—skin cancer	0.00172	0.0117	CcSEcCtD
Thiabendazole—Erythema multiforme—Vemurafenib—skin cancer	0.00164	0.0112	CcSEcCtD
Thiabendazole—Stevens-Johnson syndrome—Imiquimod—skin cancer	0.00163	0.0112	CcSEcCtD
Thiabendazole—Gastrointestinal pain—Vismodegib—skin cancer	0.00163	0.0111	CcSEcCtD
Thiabendazole—Abdominal pain—Vismodegib—skin cancer	0.00157	0.0108	CcSEcCtD
Thiabendazole—Hepatic failure—Dactinomycin—skin cancer	0.00157	0.0108	CcSEcCtD
Thiabendazole—Chills—Vemurafenib—skin cancer	0.00155	0.0106	CcSEcCtD
Thiabendazole—Asthenia—Vismodegib—skin cancer	0.00143	0.00978	CcSEcCtD
Thiabendazole—Hepatic failure—Temozolomide—skin cancer	0.00142	0.00974	CcSEcCtD
Thiabendazole—Visual impairment—Imiquimod—skin cancer	0.00142	0.00974	CcSEcCtD
Thiabendazole—Pruritus—Vismodegib—skin cancer	0.00141	0.00964	CcSEcCtD
Thiabendazole—Erythema multiforme—Imiquimod—skin cancer	0.0014	0.00955	CcSEcCtD
Thiabendazole—Tinnitus—Imiquimod—skin cancer	0.00138	0.00942	CcSEcCtD
Thiabendazole—Flushing—Imiquimod—skin cancer	0.00137	0.00938	CcSEcCtD
Thiabendazole—Diarrhoea—Vismodegib—skin cancer	0.00136	0.00932	CcSEcCtD
Thiabendazole—Chills—Imiquimod—skin cancer	0.00132	0.00907	CcSEcCtD
Thiabendazole—Vomiting—Vismodegib—skin cancer	0.00127	0.00866	CcSEcCtD
Thiabendazole—Rash—Vismodegib—skin cancer	0.00125	0.00859	CcSEcCtD
Thiabendazole—Dermatitis—Vismodegib—skin cancer	0.00125	0.00858	CcSEcCtD
Thiabendazole—Anaphylactic shock—Vemurafenib—skin cancer	0.00123	0.00842	CcSEcCtD
Thiabendazole—Nausea—Vismodegib—skin cancer	0.00118	0.00809	CcSEcCtD
Thiabendazole—Angioedema—Imiquimod—skin cancer	0.00117	0.00804	CcSEcCtD
Thiabendazole—Hepatocellular injury—Docetaxel—skin cancer	0.00117	0.00802	CcSEcCtD
Thiabendazole—Hypotension—Vemurafenib—skin cancer	0.00115	0.00787	CcSEcCtD
Thiabendazole—Haematuria—Bleomycin—skin cancer	0.00111	0.00762	CcSEcCtD
Thiabendazole—Convulsion—Imiquimod—skin cancer	0.00111	0.00762	CcSEcCtD
Thiabendazole—Stevens-Johnson syndrome—Dactinomycin—skin cancer	0.00108	0.00739	CcSEcCtD
Thiabendazole—Decreased appetite—Vemurafenib—skin cancer	0.00107	0.00732	CcSEcCtD
Thiabendazole—Fatigue—Vemurafenib—skin cancer	0.00106	0.00726	CcSEcCtD
Thiabendazole—Hypoaesthesia—Bleomycin—skin cancer	0.00104	0.00714	CcSEcCtD
Thiabendazole—Anorexia—Imiquimod—skin cancer	0.000999	0.00684	CcSEcCtD
Thiabendazole—Hyperglycaemia—Temozolomide—skin cancer	0.000997	0.00682	CcSEcCtD
Thiabendazole—Stevens-Johnson syndrome—Temozolomide—skin cancer	0.000977	0.00669	CcSEcCtD
Thiabendazole—Flushing—Bleomycin—skin cancer	0.000973	0.00666	CcSEcCtD
Thiabendazole—Hepatic failure—Docetaxel—skin cancer	0.000946	0.00648	CcSEcCtD
Thiabendazole—Chills—Bleomycin—skin cancer	0.000941	0.00644	CcSEcCtD
Thiabendazole—Somnolence—Imiquimod—skin cancer	0.000932	0.00638	CcSEcCtD
Thiabendazole—Erythema multiforme—Dactinomycin—skin cancer	0.000924	0.00633	CcSEcCtD
Thiabendazole—Dyspepsia—Imiquimod—skin cancer	0.000923	0.00632	CcSEcCtD
Thiabendazole—Decreased appetite—Imiquimod—skin cancer	0.000911	0.00624	CcSEcCtD
Thiabendazole—Flushing—Dactinomycin—skin cancer	0.000907	0.00621	CcSEcCtD
Thiabendazole—Hypersensitivity—Vemurafenib—skin cancer	0.000906	0.0062	CcSEcCtD
Thiabendazole—Fatigue—Imiquimod—skin cancer	0.000904	0.00619	CcSEcCtD
Thiabendazole—Asthenia—Vemurafenib—skin cancer	0.000882	0.00604	CcSEcCtD
Thiabendazole—Hypoaesthesia—Temozolomide—skin cancer	0.00088	0.00603	CcSEcCtD
Thiabendazole—Chills—Dactinomycin—skin cancer	0.000877	0.00601	CcSEcCtD
Thiabendazole—Pruritus—Vemurafenib—skin cancer	0.00087	0.00596	CcSEcCtD
Thiabendazole—Feeling abnormal—Imiquimod—skin cancer	0.000864	0.00592	CcSEcCtD
Thiabendazole—Gastrointestinal pain—Imiquimod—skin cancer	0.000857	0.00587	CcSEcCtD
Thiabendazole—Visual impairment—Temozolomide—skin cancer	0.000852	0.00584	CcSEcCtD
Thiabendazole—Diarrhoea—Vemurafenib—skin cancer	0.000841	0.00576	CcSEcCtD
Thiabendazole—Erythema multiforme—Temozolomide—skin cancer	0.000836	0.00573	CcSEcCtD
Thiabendazole—Abdominal pain—Imiquimod—skin cancer	0.000829	0.00568	CcSEcCtD
Thiabendazole—Tinnitus—Temozolomide—skin cancer	0.000825	0.00565	CcSEcCtD
Thiabendazole—Flushing—Temozolomide—skin cancer	0.000821	0.00562	CcSEcCtD
Thiabendazole—Leukopenia—Bleomycin—skin cancer	0.000817	0.00559	CcSEcCtD
Thiabendazole—Dizziness—Vemurafenib—skin cancer	0.000813	0.00557	CcSEcCtD
Thiabendazole—Hypoaesthesia—Fluorouracil—skin cancer	0.000811	0.00555	CcSEcCtD
Thiabendazole—Chills—Temozolomide—skin cancer	0.000794	0.00543	CcSEcCtD
Thiabendazole—Vomiting—Vemurafenib—skin cancer	0.000782	0.00535	CcSEcCtD
Thiabendazole—Rash—Vemurafenib—skin cancer	0.000775	0.00531	CcSEcCtD
Thiabendazole—Dermatitis—Vemurafenib—skin cancer	0.000774	0.0053	CcSEcCtD
Thiabendazole—Hypersensitivity—Imiquimod—skin cancer	0.000772	0.00529	CcSEcCtD
Thiabendazole—Headache—Vemurafenib—skin cancer	0.00077	0.00527	CcSEcCtD
Thiabendazole—Leukopenia—Dactinomycin—skin cancer	0.000762	0.00522	CcSEcCtD
Thiabendazole—Asthenia—Imiquimod—skin cancer	0.000752	0.00515	CcSEcCtD
Thiabendazole—Confusional state—Bleomycin—skin cancer	0.000751	0.00514	CcSEcCtD
Thiabendazole—Anaphylactic shock—Bleomycin—skin cancer	0.000745	0.0051	CcSEcCtD
Thiabendazole—Pruritus—Imiquimod—skin cancer	0.000742	0.00508	CcSEcCtD
Thiabendazole—Nausea—Vemurafenib—skin cancer	0.00073	0.005	CcSEcCtD
Thiabendazole—Vision blurred—Temozolomide—skin cancer	0.000726	0.00497	CcSEcCtD
Thiabendazole—Diarrhoea—Imiquimod—skin cancer	0.000717	0.00491	CcSEcCtD
Thiabendazole—Anorexia—Bleomycin—skin cancer	0.00071	0.00486	CcSEcCtD
Thiabendazole—Angioedema—Temozolomide—skin cancer	0.000703	0.00482	CcSEcCtD
Thiabendazole—Hypotension—Bleomycin—skin cancer	0.000696	0.00477	CcSEcCtD
Thiabendazole—Dizziness—Imiquimod—skin cancer	0.000693	0.00475	CcSEcCtD
Thiabendazole—Leukopenia—Temozolomide—skin cancer	0.000689	0.00472	CcSEcCtD
Thiabendazole—Vision blurred—Fluorouracil—skin cancer	0.000668	0.00458	CcSEcCtD
Thiabendazole—Convulsion—Temozolomide—skin cancer	0.000667	0.00457	CcSEcCtD
Thiabendazole—Vomiting—Imiquimod—skin cancer	0.000667	0.00456	CcSEcCtD
Thiabendazole—Anorexia—Dactinomycin—skin cancer	0.000662	0.00453	CcSEcCtD
Thiabendazole—Rash—Imiquimod—skin cancer	0.000661	0.00453	CcSEcCtD
Thiabendazole—Dermatitis—Imiquimod—skin cancer	0.00066	0.00452	CcSEcCtD
Thiabendazole—Headache—Imiquimod—skin cancer	0.000657	0.0045	CcSEcCtD
Thiabendazole—Stevens-Johnson syndrome—Docetaxel—skin cancer	0.00065	0.00445	CcSEcCtD
Thiabendazole—Decreased appetite—Bleomycin—skin cancer	0.000647	0.00443	CcSEcCtD
Thiabendazole—Jaundice—Docetaxel—skin cancer	0.000639	0.00437	CcSEcCtD
Thiabendazole—Leukopenia—Fluorouracil—skin cancer	0.000635	0.00435	CcSEcCtD
Thiabendazole—Confusional state—Temozolomide—skin cancer	0.000634	0.00434	CcSEcCtD
Thiabendazole—Anaphylactic shock—Temozolomide—skin cancer	0.000628	0.0043	CcSEcCtD
Thiabendazole—Nausea—Imiquimod—skin cancer	0.000623	0.00426	CcSEcCtD
Thiabendazole—Convulsion—Fluorouracil—skin cancer	0.000615	0.00421	CcSEcCtD
Thiabendazole—Feeling abnormal—Bleomycin—skin cancer	0.000614	0.0042	CcSEcCtD
Thiabendazole—Decreased appetite—Dactinomycin—skin cancer	0.000604	0.00413	CcSEcCtD
Thiabendazole—Fatigue—Dactinomycin—skin cancer	0.000599	0.0041	CcSEcCtD
Thiabendazole—Anorexia—Temozolomide—skin cancer	0.000599	0.0041	CcSEcCtD
Thiabendazole—Hypoaesthesia—Docetaxel—skin cancer	0.000585	0.00401	CcSEcCtD
Thiabendazole—Confusional state—Fluorouracil—skin cancer	0.000584	0.004	CcSEcCtD
Thiabendazole—Anaphylactic shock—Fluorouracil—skin cancer	0.000579	0.00396	CcSEcCtD
Thiabendazole—Feeling abnormal—Dactinomycin—skin cancer	0.000572	0.00392	CcSEcCtD
Thiabendazole—Gastrointestinal pain—Dactinomycin—skin cancer	0.000568	0.00389	CcSEcCtD
Thiabendazole—Visual impairment—Docetaxel—skin cancer	0.000567	0.00388	CcSEcCtD
Thiabendazole—Somnolence—Temozolomide—skin cancer	0.000559	0.00382	CcSEcCtD
Thiabendazole—Erythema multiforme—Docetaxel—skin cancer	0.000556	0.00381	CcSEcCtD
Thiabendazole—Dyspepsia—Temozolomide—skin cancer	0.000553	0.00379	CcSEcCtD
Thiabendazole—Anorexia—Fluorouracil—skin cancer	0.000552	0.00378	CcSEcCtD
Thiabendazole—Abdominal pain—Dactinomycin—skin cancer	0.000549	0.00376	CcSEcCtD
Thiabendazole—Hypersensitivity—Bleomycin—skin cancer	0.000549	0.00376	CcSEcCtD
Thiabendazole—Decreased appetite—Temozolomide—skin cancer	0.000546	0.00374	CcSEcCtD
Thiabendazole—Flushing—Docetaxel—skin cancer	0.000546	0.00374	CcSEcCtD
Thiabendazole—Fatigue—Temozolomide—skin cancer	0.000542	0.00371	CcSEcCtD
Thiabendazole—Hypotension—Fluorouracil—skin cancer	0.000541	0.0037	CcSEcCtD
Thiabendazole—Asthenia—Bleomycin—skin cancer	0.000534	0.00366	CcSEcCtD
Thiabendazole—Chills—Docetaxel—skin cancer	0.000528	0.00361	CcSEcCtD
Thiabendazole—Pruritus—Bleomycin—skin cancer	0.000527	0.00361	CcSEcCtD
Thiabendazole—Feeling abnormal—Temozolomide—skin cancer	0.000518	0.00355	CcSEcCtD
Thiabendazole—Somnolence—Fluorouracil—skin cancer	0.000515	0.00352	CcSEcCtD
Thiabendazole—Gastrointestinal pain—Temozolomide—skin cancer	0.000514	0.00352	CcSEcCtD
Thiabendazole—Hypersensitivity—Dactinomycin—skin cancer	0.000512	0.0035	CcSEcCtD
Thiabendazole—Dyspepsia—Fluorouracil—skin cancer	0.00051	0.00349	CcSEcCtD
Thiabendazole—Decreased appetite—Fluorouracil—skin cancer	0.000503	0.00345	CcSEcCtD
Thiabendazole—Asthenia—Dactinomycin—skin cancer	0.000498	0.00341	CcSEcCtD
Thiabendazole—Abdominal pain—Temozolomide—skin cancer	0.000497	0.0034	CcSEcCtD
Thiabendazole—Feeling abnormal—Fluorouracil—skin cancer	0.000477	0.00327	CcSEcCtD
Thiabendazole—Diarrhoea—Dactinomycin—skin cancer	0.000475	0.00325	CcSEcCtD
Thiabendazole—Vomiting—Bleomycin—skin cancer	0.000474	0.00324	CcSEcCtD
Thiabendazole—Rash—Bleomycin—skin cancer	0.00047	0.00322	CcSEcCtD
Thiabendazole—Dermatitis—Bleomycin—skin cancer	0.000469	0.00321	CcSEcCtD
Thiabendazole—Hypersensitivity—Temozolomide—skin cancer	0.000463	0.00317	CcSEcCtD
Thiabendazole—Leukopenia—Docetaxel—skin cancer	0.000458	0.00314	CcSEcCtD
Thiabendazole—Asthenia—Temozolomide—skin cancer	0.000451	0.00309	CcSEcCtD
Thiabendazole—Pruritus—Temozolomide—skin cancer	0.000445	0.00304	CcSEcCtD
Thiabendazole—Convulsion—Docetaxel—skin cancer	0.000444	0.00304	CcSEcCtD
Thiabendazole—Nausea—Bleomycin—skin cancer	0.000442	0.00303	CcSEcCtD
Thiabendazole—Vomiting—Dactinomycin—skin cancer	0.000442	0.00302	CcSEcCtD
Thiabendazole—Rash—Dactinomycin—skin cancer	0.000438	0.003	CcSEcCtD
Thiabendazole—Diarrhoea—Temozolomide—skin cancer	0.00043	0.00294	CcSEcCtD
Thiabendazole—Hypersensitivity—Fluorouracil—skin cancer	0.000427	0.00292	CcSEcCtD
Thiabendazole—Confusional state—Docetaxel—skin cancer	0.000421	0.00288	CcSEcCtD
Thiabendazole—Anaphylactic shock—Docetaxel—skin cancer	0.000418	0.00286	CcSEcCtD
Thiabendazole—Dizziness—Temozolomide—skin cancer	0.000415	0.00284	CcSEcCtD
Thiabendazole—Nausea—Dactinomycin—skin cancer	0.000413	0.00283	CcSEcCtD
Thiabendazole—Pruritus—Fluorouracil—skin cancer	0.00041	0.0028	CcSEcCtD
Thiabendazole—Vomiting—Temozolomide—skin cancer	0.000399	0.00274	CcSEcCtD
Thiabendazole—Anorexia—Docetaxel—skin cancer	0.000398	0.00273	CcSEcCtD
Thiabendazole—Rash—Temozolomide—skin cancer	0.000396	0.00271	CcSEcCtD
Thiabendazole—Diarrhoea—Fluorouracil—skin cancer	0.000396	0.00271	CcSEcCtD
Thiabendazole—Dermatitis—Temozolomide—skin cancer	0.000396	0.00271	CcSEcCtD
Thiabendazole—Headache—Temozolomide—skin cancer	0.000394	0.0027	CcSEcCtD
Thiabendazole—Hypotension—Docetaxel—skin cancer	0.00039	0.00267	CcSEcCtD
Thiabendazole—Dizziness—Fluorouracil—skin cancer	0.000383	0.00262	CcSEcCtD
Thiabendazole—Nausea—Temozolomide—skin cancer	0.000373	0.00256	CcSEcCtD
Thiabendazole—Somnolence—Docetaxel—skin cancer	0.000371	0.00254	CcSEcCtD
Thiabendazole—Vomiting—Fluorouracil—skin cancer	0.000368	0.00252	CcSEcCtD
Thiabendazole—Dyspepsia—Docetaxel—skin cancer	0.000368	0.00252	CcSEcCtD
Thiabendazole—Rash—Fluorouracil—skin cancer	0.000365	0.0025	CcSEcCtD
Thiabendazole—Dermatitis—Fluorouracil—skin cancer	0.000365	0.0025	CcSEcCtD
Thiabendazole—Decreased appetite—Docetaxel—skin cancer	0.000363	0.00249	CcSEcCtD
Thiabendazole—Headache—Fluorouracil—skin cancer	0.000363	0.00248	CcSEcCtD
Thiabendazole—Fatigue—Docetaxel—skin cancer	0.00036	0.00247	CcSEcCtD
Thiabendazole—Feeling abnormal—Docetaxel—skin cancer	0.000344	0.00236	CcSEcCtD
Thiabendazole—Nausea—Fluorouracil—skin cancer	0.000344	0.00235	CcSEcCtD
Thiabendazole—Gastrointestinal pain—Docetaxel—skin cancer	0.000342	0.00234	CcSEcCtD
Thiabendazole—Abdominal pain—Docetaxel—skin cancer	0.00033	0.00226	CcSEcCtD
Thiabendazole—Hypersensitivity—Docetaxel—skin cancer	0.000308	0.00211	CcSEcCtD
Thiabendazole—Asthenia—Docetaxel—skin cancer	0.0003	0.00205	CcSEcCtD
Thiabendazole—Pruritus—Docetaxel—skin cancer	0.000296	0.00202	CcSEcCtD
Thiabendazole—Diarrhoea—Docetaxel—skin cancer	0.000286	0.00196	CcSEcCtD
Thiabendazole—Dizziness—Docetaxel—skin cancer	0.000276	0.00189	CcSEcCtD
Thiabendazole—Vomiting—Docetaxel—skin cancer	0.000266	0.00182	CcSEcCtD
Thiabendazole—Rash—Docetaxel—skin cancer	0.000263	0.0018	CcSEcCtD
Thiabendazole—Dermatitis—Docetaxel—skin cancer	0.000263	0.0018	CcSEcCtD
Thiabendazole—Headache—Docetaxel—skin cancer	0.000262	0.00179	CcSEcCtD
Thiabendazole—Nausea—Docetaxel—skin cancer	0.000248	0.0017	CcSEcCtD
